An insight to the molecular interactions of the FDA approved HIV PR drugs against L38L↑N↑L PR mutant. - Zainab K. Sanusi; Thavendran Govender; Glenn E. M. Maguire; Sibusiso B. Maseko; Johnson Lin; Hendrik G. Kruger; Bahareh Honarparvar (J. Comput. Aided Mol. Des., 2018)